Immunization of human HIV-seronegative volunteers with recombinant p17/p24:Ty virus-like particles elicits HIV-1 p24-specific cellular and humoral immune responses. - Concepedia

Concepedia

Publication | Closed Access

Immunization of human HIV-seronegative volunteers with recombinant p17/p24:Ty virus-like particles elicits HIV-1 p24-specific cellular and humoral immune responses.

60

Citations

0

References

1993

Year

Séamus J. Martin, Annapurna Vyakarnam, Rachanee Cheingsong‐Popov, David Callow, Karen L. Jones, John Senior, Sally E. Adams, Alan J. Kingsman, Patricia M. Matear, F Gotch

Abstract

We conclude that hybrid HIV-1 p17/p24:Ty-VLP are capable of inducing both cellular and humoral immunity to HIV-1 Gag p17 and p24 components and are worthy of further study as a potential HIV immunotherapeutic.